IP Library Granted Patent US 8,071,751
Granted Patent B2
US 8,071,751 · App. 12/426,173 · Granted Dec 6, 2011

Human parvovirus: bocavirus

Assignee: Blood Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,751
App. No.
12/426,173
Granted
Dec 6, 2011
Kind
B2
Abstract

Provided herein are sequences of the genomes and encoded proteins of a new human parvovirus, Bocavirus-2, and variants thereof. Also provided are methods of detecting the Bocavirus-2 and diagnosing Bocavirus-2 infection, methods of treating or preventing Bocavirus-2 infection, and methods for identifying anti-Bocavirus-2 compounds.

Claims (13)

1. An isolated nucleic acid molecule comprising a nucleotide sequence having at least 80% identity to SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof.

2. An isolated nucleic acid molecule comprising a nucleotide sequence hybridizes under highly stringent conditions over the full length of SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof, wherein the hybridization reaction is incubated at 42° C. in a solution comprising 50% formamide, 5×SSC, and 1% SDS and washed at 65° C. in a solution comprising 0.2×SSC and 0.1% SDS.

3. The nucleic acid molecule of claim 1 , wherein the nucleotide sequence is at least 85% identical to SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof.

4. The nucleic acid molecule of claim 1 , wherein the nucleotide sequence is at least 90identical to SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof.

5. The nucleic acid molecule of claim 1 , wherein the nucleotide sequence is at least 95% identical to SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof.

6. An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof.

7. A composition comprising a nucleic acid molecule of claim 1 .

8. An isolated Bocavirus comprising a nucleic acid molecule of claim 1 .

9. An expression vector comprising a nucleic acid molecule of claim 1 .

10. An isolated host cell comprising the expression vector of claim 9 .

11. A method of detecting a Bocavirus nucleic acid comprising:

a) contacting a sample suspected of containing a Bocavirus nucleic acid with a nucleotide sequence that hybridizes under highly stringent conditions to a nucleotide sequence of SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:17, SEQ ID NO:25, SEQ ID NO:43, SEQ ID NO:49, or a complement thereof; and

b) detecting the presence or absence of hybridization wherein the highly stringent conditions comprise an incubation at 42° C. in a solution comprising 50% formamide, 5X SSC, and 1% SDS and an washing at 65° C. in a solution comprising 0.2X SSC and 0.1% SDS.

Assignments (2)
CHANGE OF NAME Recorded Mar 21, 2019
From: BLOOD SYSTEMS, INC.
To: VITALANT
Reel/Frame 048672/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2009
From: DELWART, ERIC; KAPOOR, AMIT
To: BLOOD SYSTEMS, INC.
Reel/Frame 023051/0630 →
Continuity (2)
Provisional Application 61045926 · Apr 17, 2008
Related Publication 20090297557A1 · Dec 3, 2009